Sanofi
CIK
1121404
Location
Paris, I0
Portfolio Value
Small
$351,158,122
Diversification
Moderately concentrated
Filing Date
Global Rank
#3,161
/ 8,605
▲ 285
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+67.2%
Period ended 3 months ago
Filed May 7, 2026 · 2mo
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+152.0%
SPY
+24.4%
Annualised alpha
+76.9%
Max drawdown
−33.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
9 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
30.1%
−1.2 pts
Top 5
89.5%
−4.7 pts
Top 10
100.0%
0.0 pts
HHI
1,933
Moderately concentrated−357
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $351,158,122 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AGMB | Agomab Therapeutics NV | 2,783,096 | $29,194,677 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
9 positions ·
$351,158,122 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Held | 12,197,737 | $105,632,402 | 30.08% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Held | 1,157,926 | $77,847,364 | 22.17% | |
| NVAX |
Novavax Inc
Healthcare
|
Held | 6,880,481 | $56,007,115 | 15.95% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Held | 821,917 | $45,583,516 | 12.98% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 2,783,096 | $29,194,677 | 8.31% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Held | 912,041 | $18,541,793 | 5.28% | |
| IMRX |
Immuneering Corp
Healthcare
|
Held | 2,708,559 | $14,274,105 | 4.06% | |
| ELDN |
Eledon Pharmaceuticals, Inc.
Healthcare
|
Held | 814,980 | $2,510,138 | 0.71% | |
| QTTB |
Q32 Bio Inc.
Healthcare
|
Held | 244,083 | $1,567,012 | 0.45% |